septerna - Search News

Order byBest matchMost fresh

News

Novo Nordisk Inks A Major Obesity Deal

· 9h · on MSN

Novo Nordisk, Septerna Agree $2.2 Billion Obesity Pill Deal

Novo Nordisk A/S is partnering with US biotech Septerna Inc. on the development of oral pills for obesity in a deal potentially worth up to $2.2 billion.The two companies will start with four development programs that use different ways to potentially treat obesity,

Continue reading

· 11h · on MSN

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments

· 11h · on MSN

Novo Nordisk and Septerna Strike $2.2 Billion Deal to Develop Obesity Pills

Novo Nordisk strikes deal with Septerna to develop obesity pills

Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...

5h

Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies

Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.

5hon MSN

This biotech’s stock rockets on oral obesity-drug partnership with Wegovy parent

Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results